According to a new report by Polaris Market Research, the global laboratory freezers market was valued at USD 4.50 billion in 2021 and is projected to reach USD 7.20 billion by 2030, expanding at a CAGR of 5.4% over the forecast period. Growth is underpinned by rising demand for blood and cell-based therapies, expanding cold-chain infrastructure, and accelerating regulatory approvals for cell and gene therapies across healthcare end markets.

The laboratory freezer market is experiencing growing demand as pharmaceutical research, biotechnology, clinical diagnostics, and biobanking activities expand worldwide. Laboratories increasingly require reliable ultra-low-temperature and specialized freezing systems to preserve biological samples, vaccines, enzymes, and other temperature-sensitive materials. Rising investments in life sciences research, personalized medicine, and drug development are encouraging laboratories to upgrade storage infrastructure, while energy-efficient technologies and advanced temperature-monitoring systems are becoming important trends across the market.

What Is Driving Laboratory Freezers Market Growth?

Demand is climbing as regulatory approvals for CAR-T and other cell therapies converge with rising global blood-collection volumes. Hospitals and biotechnology firms are prioritizing reliable cold-chain storage, pushing laboratory freezer adoption across blood banks and research institutes. Polaris analysts note that roughly 118 million blood donations were collected worldwide in 2020, positioning the segment for sustained growth through 2030, with North America emerging as the largest revenue contributor and Asia Pacific posting the fastest incremental gains.

Key Trends Shaping the Laboratory Freezers Industry

Cell and Gene Therapy Expansion

Approvals such as Kite's Tecartus and Novartis's Kymriah are driving demand for controlled-rate and ultra-low-temperature freezers, weaving cell-therapy preservation into everyday hospital and biotech procurement.

Cold-Chain Infrastructure Investment

Rising R&D and healthcare spending — U.S. healthcare expenditure reached USD 3.8 trillion in 2019 — is reinforcing the market outlook for advanced refrigeration and cryopreservation equipment.

Vaccine and Biologics Storage

Partnerships such as PHC Corporation's tie-up with Follett Products to distribute ultra-low-temperature freezers for vaccine storage reflect a broader competitive-landscape shift toward specialized biologics-grade units.

Explore The Complete Comprehensive Report Here:

https://www.polarismarketresearch.com/industry-analysis/laboratory-freezers-market 

Market Segmentation: Breaking Down the Laboratory Freezers Market

Polaris segments the global laboratory freezers market by product, end-use, and region, giving each buyer persona a citable, standalone data point.

By Product

The refrigerator segment led the market in 2021 and is expected to retain dominance, driven by frequent use of laboratory refrigerators in hospitals and clinics for short-term sample preservation, including diagnostic testing. The freezers segment, spanning ultra-low-temperature and cryopreservation units, is gaining ground as cell-therapy volumes rise.

By End-Use

Blood banks remain a leading end-use segment given daily demand for roughly 36,000 units of red blood cells in the U.S. alone, while pharmaceutical and biotechnology companies are emerging as a fast-growing segment as biologics pipelines expand.

By Region

North America held the largest revenue share in 2021, while Asia Pacific is expected to register the highest CAGR through 2030, as cryopreservation and stem-cell banking activity increases across Thailand, Malaysia, and India.

Regional Outlook: Where Is the Laboratory Freezers Market Growing Fastest?

North America led the market in 2021 on the back of a strong presence of prominent players and high R&D spending, while Asia Pacific is expected to post the fastest CAGR through 2030, driven by rising government initiatives and expanding stem-cell banking infrastructure. Within North America, the U.S. remains the largest single market; within Asia Pacific, China and India are the primary growth engines. Europe rounds out the top three, supported by strong pharmaceutical manufacturing capacity.

Competitive Landscape: Leading Laboratory Freezers Companies

Key players include Thermo Fisher Scientific, Haier Biomedical, PHC Holdings Corp, and Liebherr, who are focusing on product innovation and distribution partnerships to strengthen market position across the refrigerator and blood-bank segments outlined above. Recent moves include BioLife Solutions' launch of High-Capacity Controlled Rate Freezers and PHC Corporation's distribution partnership with Follett Products, both aimed at deepening share in North America.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the laboratory freezers market, this report benchmarks market share, segment-level pricing, and forecast data — by product, end-use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking pharmaceutical and biotech cold storage as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Macadamia Market

Conjunctivitis Treatment Market

Veterinary Reference Laboratory Market

Digital PCR Market

Pre-painted Aluminium Sheets Market

Pre-painted Aluminium Sheets Market

Glaucoma Market

Clinical Operations and Development Market

IoT Technology Market